Delivery Order SPE2DB24D2205-SPE2DB25FEGXM
Award Date 8/28/25
Potential Completion Date 9/19/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,174.80 to supply 200-unit vials of XEOMIN on April 24, 2025, with an ultimate completion date of May 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) SPE2DX with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of XEOMIN 200 unit vials, with a ceiling value of $2,234.96 and an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 21, 2025, with a ceiling value of $1,955.59 for the supply of XEOMIN 100 Unit Vials. The contract is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This award was made through competitive procedures with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for XEOMIN 100 unit vials with a ceiling value of $20,952.75. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for ultimate completion by September 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $7,263.62 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order, issued on July 23, 2025, was competitively awarded without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency (DLA) has awarded a $40,462.00 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,020,471 XEOMIN 100 unit vials. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,762.20 on August 5, 2025, for the supply of XEOMIN 100 UT vials under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The delivery order is not set-aside and must be completed by August 25, 2025. Performance will be conducted at the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $13,409.76 to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials, with a completion date of September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on August 13, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Xeomin 200 unit vials valued at $46,934.16, with completion scheduled for October 6, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for XEOMIN 100 Unit vials with a ceiling value of $8,381.10. This firm fixed price delivery order, with an ultimate completion date of August 6, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation,...